Sequential Therapy in Metastatic Renal Cell Carcinoma

Main Article Content

Bradford R Hirsch
John M Burke
Manish Agrawal
Ralph J Hauke
Thomas E Hutson
Gury Doshi
Mark T Fleming
Nicholas J Vogelzang


sequential therapy, metastasis, renal cell carcinoma


The treatment of metastatic renal cell carcinoma (mRCC) has changed dramatically in the past decade. As the number of available agents, and related volume of research, has grown, it is increasingly complex to know how to optimally treat patients. The authors are practicing medical oncologists at the US Oncology Network, the largest community-based network of oncology providers in the country, and represent the leadership of the Network's Genitourinary Research Committee. We outline our thought process in approaching sequential therapy of mRCC and the use of real-world data to inform our approach. We also highlight the evolving literature that will impact practicing oncologists in the near future.

Abstract 2268 | HTML Downloads 5551 PDF Downloads 879